Levi & Korsinsky Reminds Shareholders of an Investigation into Viking Therapeutics, Inc. (VKTX) Regarding Potential Securities Fraud Allegations
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Viking Therapeutics, Inc. (VKTX) for potential securities fraud. This follows a 9% stock price increase after positive trial data for their anti-obesity drug VK2735 was released.
November 11, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Viking Therapeutics is under investigation for potential securities fraud following a 9% stock price increase after positive trial data for their drug VK2735.
The investigation into potential securities fraud could negatively impact investor confidence and lead to a short-term decline in VKTX's stock price, despite the recent positive trial data.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100